Department of Medicinal Chemistry 4, Centre de Recherche Pierre Fabre, 17 Avenue Jean Moulin, 81106 Castres Cedex, France.
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1735-9. doi: 10.1016/j.bmcl.2010.01.050. Epub 2010 Jan 20.
Two series of new PAR1 antagonists have been identified. The first incorporates a cinnamoylpiperidine motif and the second a cinnamoylpyridine pattern. The synthesis, biological activity and structure-activity relationship of these compounds are presented. In each series, one analog showed potent in vivo antithrombotic activity in a rat AV shunt model, with up to 53% inhibition at 1.25mpk iv for compound 30.
已经鉴定出了两类新的 PAR1 拮抗剂。第一类包含一个肉桂酰哌啶基序,第二类包含一个肉桂酰吡啶模式。介绍了这些化合物的合成、生物活性和构效关系。在每个系列中,一种类似物在大鼠动静脉分流模型中显示出强大的体内抗血栓活性,化合物 30 在 1.25mpk iv 时的抑制率高达 53%。